Stage IV Childhood Large Cell Lymphoma Completed Phase 0 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0030017 (Stage IV Childhood Large Cell Lymphoma)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01959477Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell TransplantTreatment